Global Montelukast Sodium Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032
Description
Market Overview
According to DIResearch's in-depth investigation and research, the global Montelukast Sodium market size will reach 521.38 Million USD in 2025 and is projected to reach 1,119.17 Million USD by 2032, with a CAGR of 11.53% (2025-2032). Notably, the China Montelukast Sodium market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Montelukast sodium is a medication that belongs to a class of drugs called leukotriene receptor antagonists. It is primarily used for the treatment and management of asthma and allergic rhinitis (hay fever) in both adults and children. Montelukast sodium works by blocking the action of leukotrienes, which are substances released in the body during an allergic reaction or asthma attack. By inhibiting leukotriene activity, it helps to reduce inflammation, constriction of airways, and other symptoms associated with asthma and allergies. This medication is available in tablet or chewable tablet form, and it is typically taken orally once a day. Montelukast sodium is often prescribed as a long-term preventive therapy to control asthma symptoms and improve overall respiratory function.
The major global manufacturers of Montelukast Sodium include Morepen Laboratories, Mylan, TAPI, MSN Laboratories, Ultratech India, Aurobindo Pharma, Hetero Labs, Unimark Remedies, Jubilant Cadista, Aamorb Pharmaceuticals, Sudarshan Group, Ortin Laboratories, Adley Group, Vamsi Labs, Medopharm, Hengyuan Pharmaceutical, Arromax Pharmaceutical Technology, Lihe Wuhan New Chemical Materials, Shanghai Huachu Chemical, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Montelukast Sodium. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Montelukast Sodium market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Montelukast Sodium market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Montelukast Sodium industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Montelukast Sodium Include:
Morepen Laboratories
Mylan
TAPI
MSN Laboratories
Ultratech India
Aurobindo Pharma
Hetero Labs
Unimark Remedies
Jubilant Cadista
Aamorb Pharmaceuticals
Sudarshan Group
Ortin Laboratories
Adley Group
Vamsi Labs
Medopharm
Hengyuan Pharmaceutical
Arromax Pharmaceutical Technology
Lihe Wuhan New Chemical Materials
Shanghai Huachu Chemical
Montelukast Sodium Product Segment Include:
Montelukast Sodium Amorphous
Montelukast Sodium Crystalline
Montelukast Sodium Product Application Include:
Tablets
Chewable Tablet
Oral Solution
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Montelukast Sodium Industry PESTEL Analysis
Chapter 3: Global Montelukast Sodium Industry Porter's Five Forces Analysis
Chapter 4: Global Montelukast Sodium Major Regional Market Size (Sales, Revenue, Price) and Forecast Analysis
Chapter 5: Global Montelukast Sodium Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 6: Global Montelukast Sodium Sales, Revenue, Price and Forecast by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 8: Industrial Chain Analysis, Montelukast Sodium Different Application Market Analysis (Sales and Revenue), Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
According to DIResearch's in-depth investigation and research, the global Montelukast Sodium market size will reach 521.38 Million USD in 2025 and is projected to reach 1,119.17 Million USD by 2032, with a CAGR of 11.53% (2025-2032). Notably, the China Montelukast Sodium market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Montelukast sodium is a medication that belongs to a class of drugs called leukotriene receptor antagonists. It is primarily used for the treatment and management of asthma and allergic rhinitis (hay fever) in both adults and children. Montelukast sodium works by blocking the action of leukotrienes, which are substances released in the body during an allergic reaction or asthma attack. By inhibiting leukotriene activity, it helps to reduce inflammation, constriction of airways, and other symptoms associated with asthma and allergies. This medication is available in tablet or chewable tablet form, and it is typically taken orally once a day. Montelukast sodium is often prescribed as a long-term preventive therapy to control asthma symptoms and improve overall respiratory function.
The major global manufacturers of Montelukast Sodium include Morepen Laboratories, Mylan, TAPI, MSN Laboratories, Ultratech India, Aurobindo Pharma, Hetero Labs, Unimark Remedies, Jubilant Cadista, Aamorb Pharmaceuticals, Sudarshan Group, Ortin Laboratories, Adley Group, Vamsi Labs, Medopharm, Hengyuan Pharmaceutical, Arromax Pharmaceutical Technology, Lihe Wuhan New Chemical Materials, Shanghai Huachu Chemical, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Montelukast Sodium. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Montelukast Sodium market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Montelukast Sodium market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Montelukast Sodium industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Montelukast Sodium Include:
Morepen Laboratories
Mylan
TAPI
MSN Laboratories
Ultratech India
Aurobindo Pharma
Hetero Labs
Unimark Remedies
Jubilant Cadista
Aamorb Pharmaceuticals
Sudarshan Group
Ortin Laboratories
Adley Group
Vamsi Labs
Medopharm
Hengyuan Pharmaceutical
Arromax Pharmaceutical Technology
Lihe Wuhan New Chemical Materials
Shanghai Huachu Chemical
Montelukast Sodium Product Segment Include:
Montelukast Sodium Amorphous
Montelukast Sodium Crystalline
Montelukast Sodium Product Application Include:
Tablets
Chewable Tablet
Oral Solution
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Montelukast Sodium Industry PESTEL Analysis
Chapter 3: Global Montelukast Sodium Industry Porter's Five Forces Analysis
Chapter 4: Global Montelukast Sodium Major Regional Market Size (Sales, Revenue, Price) and Forecast Analysis
Chapter 5: Global Montelukast Sodium Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 6: Global Montelukast Sodium Sales, Revenue, Price and Forecast by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 8: Industrial Chain Analysis, Montelukast Sodium Different Application Market Analysis (Sales and Revenue), Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
Table of Contents
165 Pages
- 1 Montelukast Sodium Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Montelukast Sodium Product by Type
- 1.2.1 Montelukast Sodium Amorphous
- 1.2.2 Montelukast Sodium Crystalline
- 1.3 Montelukast Sodium Product by Application
- 1.3.1 Tablets
- 1.3.2 Chewable Tablet
- 1.3.3 Oral Solution
- 1.4 Global Montelukast Sodium Market Revenue and Sales Analysis
- 1.4.1 Global Montelukast Sodium Revenue Market Size Analysis (2020-2032)
- 1.4.2 Global Montelukast Sodium Sales Market Size Analysis (2020-2032)
- 1.4.3 Global Montelukast Sodium Market Sales Price Trend Analysis (2020-2032)
- 1.5 Montelukast Sodium Market Development Status and Trends
- 1.5.1 Montelukast Sodium Industry Development Status Analysis
- 1.5.2 Montelukast Sodium Industry Development Trends Analysis
- 2 Montelukast Sodium Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Montelukast Sodium Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Montelukast Sodium Market Analysis by Country
- 4.1 Global Montelukast Sodium Market Size Analysis by Country: 2024 VS 2025 VS 2032
- 4.1.1 Global Montelukast Sodium Revenue and Market Share by Country (2020-2025)
- 4.1.2 Global Montelukast Sodium Revenue and Market Share Forecast by Country (2026-2032)
- 4.2 Global Montelukast Sodium Sales Analysis by Country: 2024 VS 2025 VS 2032
- 4.2.1 Global Montelukast Sodium Sales and Market Share by Country (2020-2025)
- 4.2.2 Global Montelukast Sodium Sales and Market Share Forecast by Country (2026-2032)
- 4.3 United States Montelukast Sodium Market Sales, Revenue and Growth Rate (2020-2032)
- 4.4 Germany Montelukast Sodium Market Sales, Revenue and Growth Rate (2020-2032)
- 4.5 Japan Montelukast Sodium Market Sales, Revenue and Growth Rate (2020-2032)
- 4.6 China Montelukast Sodium Market Sales, Revenue and Growth Rate (2020-2032)
- 4.7 France Montelukast Sodium Market Sales, Revenue and Growth Rate (2020-2032)
- 4.8 U.K. Montelukast Sodium Market Sales, Revenue and Growth Rate (2020-2032)
- 4.9 South Korea Montelukast Sodium Market Sales, Revenue and Growth Rate (2020-2032)
- 4.10 Canada Montelukast Sodium Market Sales, Revenue and Growth Rate (2020-2032)
- 4.11 Italy Montelukast Sodium Market Sales, Revenue and Growth Rate (2020-2032)
- 4.12 Russia Montelukast Sodium Market Sales, Revenue and Growth Rate (2020-2032)
- 4.13 Mexico Montelukast Sodium Market Sales, Revenue and Growth Rate (2020-2032)
- 4.14 Brazil Montelukast Sodium Market Sales, Revenue and Growth Rate (2020-2032)
- 4.15 India Montelukast Sodium Market Sales, Revenue and Growth Rate (2020-2032)
- 4.16 Vietnam Montelukast Sodium Market Sales, Revenue and Growth Rate (2020-2032)
- 4.17 Thailand Montelukast Sodium Market Sales, Revenue and Growth Rate (2020-2032)
- 4.18 South Africa Montelukast Sodium Market Sales, Revenue and Growth Rate (2020-2032)
- 5 Competition by Manufacturers
- 5.1 Global Montelukast Sodium Market Sales, Revenue and Sales Price by Key Manufacturers (2021-2025)
- 5.1.1 Global Montelukast Sodium Market Sales by Key Manufacturers (2021-2025)
- 5.1.2 Global Montelukast Sodium Market Revenue by Key Manufacturers (2021-2025)
- 5.1.3 Global Montelukast Sodium Average Sales Price by Manufacturers (2021-2025)
- 5.2 Montelukast Sodium Competitive Landscape Analysis and Market Dynamic
- 5.2.1 Montelukast Sodium Competitive Landscape Analysis
- 5.2.2 Global Key Manufacturers Headquarter and Key Area Sales
- 5.2.3 Market Dynamic
- 6 Montelukast Sodium Market Analysis by Type
- 6.1 Global Montelukast Sodium Market Revenue Analysis by Type
- 6.1.1 Global Montelukast Sodium Market Size Analysis by Type: 2024 & 2025 & 2032
- 6.1.2 Global Montelukast Sodium Revenue and Forecast Analysis by Type (2020-2032)
- 6.2 Global Montelukast Sodium Market Sales and Forecast Analysis by Type (2020-2032)
- 6.3 Global Montelukast Sodium Sales Price Trend Analysis by Type (2020-2032)
- 7 Key Companies Analysis
- 7.1 Morepen Laboratories
- 7.1.1 Morepen Laboratories Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.1.2 Morepen Laboratories Montelukast Sodium Product Portfolio
- 7.1.3 Morepen Laboratories Montelukast Sodium Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.2 Mylan
- 7.2.1 Mylan Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.2.2 Mylan Montelukast Sodium Product Portfolio
- 7.2.3 Mylan Montelukast Sodium Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.3 TAPI
- 7.3.1 TAPI Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.3.2 TAPI Montelukast Sodium Product Portfolio
- 7.3.3 TAPI Montelukast Sodium Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.4 MSN Laboratories
- 7.4.1 MSN Laboratories Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.4.2 MSN Laboratories Montelukast Sodium Product Portfolio
- 7.4.3 MSN Laboratories Montelukast Sodium Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.5 Ultratech India
- 7.5.1 Ultratech India Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.5.2 Ultratech India Montelukast Sodium Product Portfolio
- 7.5.3 Ultratech India Montelukast Sodium Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.6 Aurobindo Pharma
- 7.6.1 Aurobindo Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.6.2 Aurobindo Pharma Montelukast Sodium Product Portfolio
- 7.6.3 Aurobindo Pharma Montelukast Sodium Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.7 Hetero Labs
- 7.7.1 Hetero Labs Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.7.2 Hetero Labs Montelukast Sodium Product Portfolio
- 7.7.3 Hetero Labs Montelukast Sodium Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.8 Unimark Remedies
- 7.8.1 Unimark Remedies Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.8.2 Unimark Remedies Montelukast Sodium Product Portfolio
- 7.8.3 Unimark Remedies Montelukast Sodium Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.9 Jubilant Cadista
- 7.9.1 Jubilant Cadista Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.9.2 Jubilant Cadista Montelukast Sodium Product Portfolio
- 7.9.3 Jubilant Cadista Montelukast Sodium Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.10 Aamorb Pharmaceuticals
- 7.10.1 Aamorb Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.10.2 Aamorb Pharmaceuticals Montelukast Sodium Product Portfolio
- 7.10.3 Aamorb Pharmaceuticals Montelukast Sodium Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.11 Sudarshan Group
- 7.11.1 Sudarshan Group Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.11.2 Sudarshan Group Montelukast Sodium Product Portfolio
- 7.11.3 Sudarshan Group Montelukast Sodium Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.12 Ortin Laboratories
- 7.12.1 Ortin Laboratories Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.12.2 Ortin Laboratories Montelukast Sodium Product Portfolio
- 7.12.3 Ortin Laboratories Montelukast Sodium Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.13 Adley Group
- 7.13.1 Adley Group Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.13.2 Adley Group Montelukast Sodium Product Portfolio
- 7.13.3 Adley Group Montelukast Sodium Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.14 Vamsi Labs
- 7.14.1 Vamsi Labs Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.14.2 Vamsi Labs Montelukast Sodium Product Portfolio
- 7.14.3 Vamsi Labs Montelukast Sodium Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.15 Medopharm
- 7.15.1 Medopharm Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.15.2 Medopharm Montelukast Sodium Product Portfolio
- 7.15.3 Medopharm Montelukast Sodium Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.16 Hengyuan Pharmaceutical
- 7.16.1 Hengyuan Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.16.2 Hengyuan Pharmaceutical Montelukast Sodium Product Portfolio
- 7.16.3 Hengyuan Pharmaceutical Montelukast Sodium Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.17 Arromax Pharmaceutical Technology
- 7.17.1 Arromax Pharmaceutical Technology Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.17.2 Arromax Pharmaceutical Technology Montelukast Sodium Product Portfolio
- 7.17.3 Arromax Pharmaceutical Technology Montelukast Sodium Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.18 Lihe Wuhan New Chemical Materials
- 7.18.1 Lihe Wuhan New Chemical Materials Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.18.2 Lihe Wuhan New Chemical Materials Montelukast Sodium Product Portfolio
- 7.18.3 Lihe Wuhan New Chemical Materials Montelukast Sodium Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.19 Shanghai Huachu Chemical
- 7.19.1 Shanghai Huachu Chemical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.19.2 Shanghai Huachu Chemical Montelukast Sodium Product Portfolio
- 7.19.3 Shanghai Huachu Chemical Montelukast Sodium Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 8 Industry Chain Analysis
- 8.1 Montelukast Sodium Industry Chain Analysis
- 8.2 Montelukast Sodium Industry Upstream Supply Analysis
- 8.2.1 Upstream Key Raw Material Supply Analysis
- 8.2.2 Raw Material Suppliers and Contact Information
- 8.3 Montelukast Sodium Product Downstream Application Analysis
- 8.3.1 Global Montelukast Sodium Revenue Market Size by Application: 2024 & 2025 & 2032
- 8.3.2 Global Montelukast Sodium Revenue and Forecast Analysis by Application (2020-2032)
- 8.3.3 Global Montelukast Sodium Sales and Forecast Analysis by Application (2020-2032)
- 8.4 Montelukast Sodium Typical Downstream Customers
- 8.5 Montelukast Sodium Sales Channel Analysis
- 9 Research Findings and Conclusion
- 10 Methodology and Data Source
- 10.1 Methodology/Research Approach
- 10.2 Research Scope
- 10.3 Benchmarks and Assumptions
- 10.4 Date Source
- 10.4.1 Primary Sources
- 10.4.2 Secondary Sources
- 10.5 Data Cross Validation
- 10.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
